The limits of monolithic integration, together with advances in chip interconnect and packaging technologies, have spurred the growth of heterogeneous advanced packaging where multiple dies are ...

According to the companies, autonomous testing began in December 2025 and is intended to support a commercial launch expected ...

Digital analytics teams have made great strides in driving value through testing and optimizing. But many are still working in isolated digital channel silos — and that leaves money on the table. For ...

Health plans and patients need to know they can trust their diagnostic service provider, because genetic tests are not always the best option. When the human genome was first sequenced in the early ...

Multigene assays allow for patients to receive personalized breast cancer treatment by identifying promising therapeutic targets, which could improve patient clinical outcomes in the long term and ...

Cancer diagnosis used to be a simple, binary call: either someone had the disease or they didn’t. And patients with the same broad class of cancer tend to receive the same class of therapy. It was a ...

About 50% of patients with CLL/SLL have high-risk molecular features limiting effectiveness of certain treatments; a blood test can identify these features and help guide which therapy is most likely ...

The author writes: "When I attended mediation as a client with settlement authority, what I appreciated most about the process was having my positions tested. The tests would often come late in the ...

Value stream management involves people in the organization to examine workflows and other processes to ensure they are deriving the maximum value from their efforts while eliminating waste — of ...